drug discovery and development

Autobahn collaboration to accelerate UCSF innovation from bench to bedside

Fri Jan 8, 2021

SARS-CoV-2 may spur growth of molecular “railways” out of infected cells, School scientists show

Thu Jul 2, 2020

NIAID/NIH

SARS-CoV-2 viral particles and human cells

UCSF-led collaboration uncovers new avenues for COVID-19 drug discovery

QBI Coronavirus Research Group identifies drugs that block SARS-CoV-2 in the laboratory

Thu May 28, 2020

Susan Merrell

Nevan Krogan, PhD (standing), leads a meeting of the QBI Coronavirus Research Group with fellow UCSF faculty members (seated from left) Danica Galonić Fujimori, PhD; Natalia Jura, PhD; James Fraser, PhD; and David Agard, PhD.

The QBI Coronavirus Research Group found six drugs that effectively beat back SARS-COV-2 in the laboratory.

In clinical work and discovery science, the School takes on COVID-19

Tue May 12, 2020

Human cells infected with SARS-CoV-2 virus

NIAID/NIH

The UCSF School of Pharmacy is moving quickly against the COVID-19 pandemic, applying a scientific mindset to challenges being raised during the crisis.

Arkin receives Ono Pharma Foundation Breakthrough Science Initiative Award

Fri Aug 31, 2018

Elisabeth Fall

Michelle Arkin, PhD

Michelle Arkin, PhD, has received the 2018 Breakthrough Science Initiative Award from the Ono Pharma Foundation to study a class of proteins, called 14-3-3 proteins, known to be involved in various cancers, with the ultimate goal of enabling discoveries that lead to new ways to treat cancer.

UCSF School of Pharmacy joins data-sharing partnership to speed cancer drugs

Thu Nov 2, 2017

Lawrence Livermore National Laboratory

A supercomputer in the Lawrence Livermore National Laboratory will be used in Project ATOM, a new public-private project that aims to speed discovery of new drug therapies.

A pioneering public/private consortium is poised to turn the marathon of drug discovery into a team relay, maybe even a short one.

Computer models speed UCSF scientists toward psychiatric drug discoveries

Mon Oct 23, 2017

For decades, scientists have wanted to be able to study dopamine receptors one by one. The brain’s dopamine receptors are responsible for a variety of behaviors, such as reward seeking, and are also involved in psychiatric illnesses like schizophrenia.

Jacobson named chair of the Department of Pharmaceutical Chemistry

Wed Aug 12, 2015

Elisabeth Fall

Matt Jacobson, PhD

Renowned researcher and educator Matthew Jacobson, PhD, has been named the new chair of the UCSF School of Pharmacy’s Department of Pharmaceutical Chemistry. His appointment by Dean B. Joseph Guglielmo, PharmD, will be effective January 15, 2016.

Computer models successfully predict drug side effects

Mon Jun 11, 2012

New computer models were able to successfully predict negative side effects for hundreds of currently marketed drugs, report researchers from the UCSF School of Pharmacy, SeaChange Pharmaceuticals, and Novartis Institutes for Biomedical Research in

Fischbach receives Packard Fellowship

Mon Oct 17, 2011

Michael Fischbach, PhD

Michael Fischbach, PhD, who studies drug-like molecules produced by human gut bacteria, has been awarded one the 16 prestigious 2011 Packard Fellowships in Science and Engineering.

Topics and Expertise: drug discovery and development